Welcome to the AD/PD™ 2021 Interactive Program
The congress will officially run on Central European Time (CET) - Barcelona Time
To convert the congress times to your local time Click Here
Icons Legend: ![]()
- Live Session | 
- On Demand Session | 
- On Demand with Live Q&A
The viewing of sessions, cannot be accessed from this conference calendar. All sessions are accessible via the Main Lobby.
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Session Icon
WELCOME AND INTRODUCTION
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
13:30 - 13:40
Presenter
Session Icon
INTRANASAL INSULIN AS A THERAPY FOR ALZHEIMER’S DISEASE
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
13:40 - 14:00
Presenter
Session Icon
CLINICAL TRIAL OF BYDUREON (EXENATIDE) IN PD PATIENTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
14:00 - 14:20
Presenter
Session Icon
EVALUATION OF LIRAGLUTIDE IN THE TREATMENT OF ALZHEIMER'S DISEASE
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
14:20 - 14:40
Presenter
Session Icon
CLINICAL TRIAL OF LIRAGLUTIDE IN PD PATIENTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
14:40 - 15:00
Session Icon
IMPAIRED BRAIN INSULIN SIGNALLING IN SYNUCLEINOPATHIES: A TRANSLATIONAL STUDY
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
15:00 - 15:20
Presenter
Session Icon
INSULIN SIGNALING BIOMARKERS IN BLOOD EXOSOMES OF AD AND PD PATIENTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
15:20 - 15:40
Session Icon
DIRECT DEMONSTRATION OF BRAIN INSULIN RESISTANCE IN ALZHEIMER’S AND PARKINSON’S DISEASE DEMENTIA AND ITS ALLEVIATION WITH INCRETIN RECEPTOR AGONISTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
15:40 - 16:00
Presenter
Session Icon
PERMEABILITY OF THE BLOOD-BRAIN BARRIER TO INSULIN AND INCRETINS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
16:00 - 16:20
Presenter
Session Icon
GLUCAGON-LIKE PEPTIDE-1(GLP-1) RECEPTOR AGONISTS AS A TREATMENT STRATEGY FOR NEURODEGENERATIVE DISORDERS; FOCUSING ON PARKINSON'S DISEASE AND TRAUMATIC BRAIN INJURY
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
16:20 - 16:40
Presenter
Session Icon
THE NEUROPROTECTIVE EFFECTS OF INSULIN/IGF-1/GLP-1 SIGNALLING RECOVERY IN TYPE 2 DIABETES AND NEURODEGENERATIVE DISEASES
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
16:40 - 17:00
Presenter
Session Icon
NOVEL DUAL GLP-1/GIP RECEPTOR AGONISTS AND ARE SUPERIOR TO SINGLE RECEPTOR AGONISTS IN ANIMAL MODELS OF ALZHEIMER AND PARKINSON'S DISEASE
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
17:00 - 17:20
Presenter
Session Icon